TVAX Biomedical

The Natural Cancer Treatment

Home

Corporate

Management

Scientific Advisors

Technology

Science - Preclinical

Science - Humans

TVAX Immunotherapy

Selected References

Clinical Outcomes

Brain Cancer Studies

Kidney Cancer Studies

Preclinical Studies

Clinical Trials

Links

Contact Us

 
 
 
Scientific studies of the relationships between cancer and the immune system have demonstrated that the immune system can be manipulated to produce "killer" T cells that specifically recognize and kill cancer cells and reject growing cancers.

TVAX Immunotherapy is a medical strategy that stimulates the immune system to produce high numbers of "killer" T cells and then delivers those 'killer" T cells into growing cancers.  "Killer" T cells enter cancer tissue, kill cancer cells and reject growing cancers without the harmful side effects that are normally associated with cancer treatment. 






Return to Home Page



© 2009 TVAX Biomedical